Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (DCOY)

CUSIP: 79400X503

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
7,157,222
Total 13F shares
79,250
Share change
+78,713
Total reported value
$51,429
Price per share
$0.65
Number of holders
9
Value change
+$49,570
Number of buys
7
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 79400X503?
CUSIP 79400X503 identifies DCOY - Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (DCOY) as of Q4 2025

As of 31 Dec 2025, Decoy Therapeutics Inc. - Common Stock, $0.0001 par value per share (DCOY) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,250 shares. The largest 9 holders included Warberg Asset Management LLC, StoneX Group Inc., XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, OSAIC HOLDINGS, INC., and DANSKE BANK A/S. This page lists 9 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.